These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 28762137

  • 1. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA, Estilo CL, Huryn JM, Chi P, Antonescu CR.
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [Abstract] [Full Text] [Related]

  • 2. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
    Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR.
    Am J Surg Pathol; 2016 Apr; 40(4):479-89. PubMed ID: 26645727
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative Analysis of Head and Neck and Non-Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Patel TD, Shaigany K, Fang CH, Park RC, Baredes S, Eloy JA.
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):113-20. PubMed ID: 26408559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.
    Mito JK, Qian X, Doyle LA, Hornick JL, Jo VY.
    Am J Clin Pathol; 2017 Aug 01; 148(2):179-189. PubMed ID: 28898989
    [Abstract] [Full Text] [Related]

  • 7. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL, Nielsen GP.
    Am J Surg Pathol; 2019 Oct 01; 43(10):1323-1330. PubMed ID: 31107719
    [Abstract] [Full Text] [Related]

  • 8. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE.
    J Neurosurg; 2017 Jan 01; 126(1):319-329. PubMed ID: 27035165
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
    Schaefer IM, Fletcher CD, Hornick JL.
    Mod Pathol; 2016 Jan 01; 29(1):4-13. PubMed ID: 26585554
    [Abstract] [Full Text] [Related]

  • 12. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
    Patrizi S, Miele E, Falcone L, Vallese S, Rossi S, Barresi S, Giovannoni I, Pedace L, Nardini C, Masier I, Abballe L, Cacchione A, Russo I, Di Giannatale A, Di Ruscio V, Salgado CM, Mastronuzzi A, Ciolfi A, Tartaglia M, Milano GM, Locatelli F, Alaggio R.
    Clin Epigenetics; 2024 Jan 04; 16(1):9. PubMed ID: 38178234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.
    Le Guellec S, Decouvelaere AV, Filleron T, Valo I, Charon-Barra C, Robin YM, Terrier P, Chevreau C, Coindre JM.
    Am J Surg Pathol; 2016 Jul 04; 40(7):896-908. PubMed ID: 27158754
    [Abstract] [Full Text] [Related]

  • 16. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
    Lyskjaer I, Lindsay D, Tirabosco R, Steele CD, Lombard P, Strobl AC, Rocha AM, Davies C, Ye H, Bekers E, Ingruber J, Lechner M, Amary F, Pillay N, Flanagan AM.
    J Pathol; 2020 Oct 04; 252(2):151-164. PubMed ID: 32666581
    [Abstract] [Full Text] [Related]

  • 17. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
    Arshi A, Tajudeen BA, St John M.
    Oral Oncol; 2015 Dec 04; 51(12):1088-94. PubMed ID: 26442813
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N, Yoshida A, Ichikawa H, Mori T, Nakamura M, Kawai A, Hiraoka N.
    Histopathology; 2017 Feb 04; 70(3):385-393. PubMed ID: 27580378
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C.
    Eur J Cancer; 2016 Mar 04; 56():77-84. PubMed ID: 26824706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.